The Disease Burden and Treatment Situation of Osteoporosis

Jing Wu,Xinling Liu,Xiaoning He,Liman Ding
DOI: https://doi.org/10.369/j.issn.1674-3830.2015.1.016
2015-01-01
Abstract:Objective:To summarize the epidemiological features, disease burden, diagnosis, and treatment situation of osteoporosis in the world, and provide reference for health care policy makers, clinical workers, and patients to understand the clinical and health-economical status of osteoporosis. Methods:Literatures and Guidelines about osteoporosis written in English and Chinese were searched and summarized. Results and Conclusions: Due to lack of obvious symptoms in early stage, the diagnosis and treatment rate of osteoporosis was less than 20%. Domestically and internationally published studies showed that the proportion of diagnosis and treatment among patients with fracture is only 20%-30%. The total cost of osteoporosis is high, which brings heavy economic burden to patients and the health care system. Alendronate, Risedronate and Teriparatide have been used as the first-line therapy agents. Early diagnosis and medical interventions are important to control osteoporosis.
What problem does this paper attempt to address?